Silverback Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Silverback Therapeutics, Inc. - overview
Established
2016
Location
Seattle, WA, US
Primary Industry
Biotechnology
About
Founded in 2016 and based in Washington, US, Silverback Therapeutics, Inc. operates as a biopharmaceutical company that develops tissue-targeted therapeutics to treat patients with cancer, fibrosis, and other infectious diseases.
Current Investors
OrbiMed Advisors, Alexandria Venture Investments, Celgene
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.silverbacktx.com
Verticals
Manufacturing
Company Stage
Series C/Round 3
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.